Medicine and Dentistry
Von Willebrand Factor
85%
Von Willebrand Disease
82%
Blood Stasis
81%
Diagnosis
77%
Patient
74%
Assay
66%
Laboratory
62%
Thrombosis
44%
Combination Therapy
35%
Diseases
35%
Platelet
29%
Thrombocyte Function
27%
Laboratory Test
26%
Plasma
24%
Bleeding
24%
Blood
21%
Blood Clotting Factor 8
20%
Antithrombotic
19%
Assessment
19%
COVID-19
18%
Heparin
18%
Heparin-Induced Thrombocytopenia
17%
PFA-100
16%
Collagen
16%
Therapeutic Procedure
16%
Antibody
16%
Coagulation
16%
Venous Thromboembolism
16%
D-Dimer
16%
Development
15%
Bleeding Disorder
15%
Blood Clotting Factor
15%
Lupus Anticoagulant
15%
Vaccine
14%
Inpatient
13%
Monitoring
13%
Cells
13%
Prothrombin Time
12%
Fibrinogen
12%
Age
11%
Thrombocyte Aggregation
11%
Thrombotic Thrombocytopenic Purpura
11%
Screening
10%
Marker
10%
Association
10%
Evaluation Study
9%
Thrombophilia
9%
Blood Clotting
9%
Desmopressin
9%
Thrombocyte Factor 4
9%
Biochemistry, Genetics and Molecular Biology
Von Willebrand Factor
100%
Von Willebrand Disease
63%
Sample
57%
Hemostasis
44%
Laboratory Test
36%
Partial Thromboplastin Time
32%
Coagulation
24%
Prothrombin Time
24%
Heparin
19%
Lupus Anticoagulant
18%
Electric Potential
17%
Time
17%
Factor VIII
17%
Fibrinogen
14%
Collagen
13%
ADAMTS13
12%
D-Dimer
12%
Protein C
11%
Platelet
11%
Von Willebrand Factor
11%
Ristocetin
11%
Heparin-Induced Thrombocytopenia
10%
Haemophilia
10%
Antibody
10%
Blood Coagulation Factor
8%
Thrombocytopenia
8%
Thrombocyte Function
7%
Coagulation Testing
7%
Antiphospholipid Antibody
7%
Development
6%
Mutation
6%
Age
6%
Quality Control
6%
Thrombotic Thrombocytopenic Purpura
6%
Thrombocyte Aggregation
6%
ABO Blood Group System
5%
Thrombophilia
5%
Consensus
5%
Cofactors
5%
Coronavirinae
5%
Hematology
5%
Activated Protein C Resistance
5%
Coagulation System
5%
Classification
5%
Chemoluminescence
5%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
34%
Heparin
28%
Thrombosis
25%
Direct Oral Anticoagulant
18%
Lupus Anticoagulant
17%
Heparin Induced Thrombocytopenia
17%
Vaccine
13%
Drug
13%
Venous Thromboembolism
12%
Rivaroxaban
11%
Thrombotic Thrombocytopenic Purpura
10%
Diseases
9%
Antibody
9%
Bleeding
9%
Thrombocyte Factor 4
9%
Vein Thrombosis
9%
Antivitamin K
8%
Dabigatran
8%
Thrombin
8%
Blood Clotting Factor
8%
Apixaban
7%
Reagent
7%
Warfarin
6%
Cardiovascular Disease
6%
Thromboplastin
6%
Biological Product
5%
Von Willebrand Disease
5%
Von Willebrand Factor
5%
Hemophilia
5%
